Loading profile…
Riskpilot
← Back to search
Sign in
Get full access
TM
Thomas Michael Frimurer
Stakeholder, Thomas Drug Design
Under Elmene 11, 4.
DK
3 active roles
Watchlist
Share
Overview
Companies & roles
Network
Active roles
3
directorships & management
Past roles
1
historical positions
Dissolved companies
1
in directorship history
Career timeline
2022 – now
Founder, Solid Therapeutics ApS
2018 – now
Chief Executive Officer, Frimurer Holdings ApS
2018 – 2025
Management, Ankrin Therapeutics ApS
2016 – now
Stakeholder, Thomas Drug Design
Personal details
Nationality
DK
Address
Under Elmene 11, 4.
Active roles
3 positions
Company
Role
Period
Ownership
Status
Thomas Drug Design
CVR 37848158
Other
Stakeholder
Since 2016
—
Active
Frimurer Holdings ApS
CVR 39786494
Management
Chief Executive Officer
Since 2018
—
Active
Solid Therapeutics ApS
CVR 43007068
Other
Founder
Since 2022
—
Active
Historical roles
1 positions
Company
Role
Period
Ownership
Status
Ankrin Therapeutics ApS
CVR 39788705
Management
Management
2018 – 2025
—
Dissolved
1 dissolved company in directorship history
Ankrin Therapeutics ApS
CVR 39788705 · Dissolved 2025 · —
Role: Management
Co-directors & shared companies
Person
Role
Shared companies
Profile
US
Ulrik Svane Sørensen
Chairman
1
company
View profile
JA
Jimmy Arnold Van heusden
Chairman
1
company
View profile
AG
Anja Groth
Management
1
company
View profile
Company network
Active roles
Thomas Michael Frimurer
Thomas Drug Design
Stakeholder
Frimurer Holdings ApS
Chief Executive Officer
Solid Therapeutics ApS
Founder